Skip to main content
MDLNMedline Inc.Hold5.7·$36.14+0.25%
MDLN · Concentration risk · 10-K extracted

Medline (MDLN) concentration risks

Updated

The most significant concentration Medline discloses is Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) at 69%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Medline’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH1
MEDIUM0
LOW1
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partyCustomer
69%

Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs)

10-K Item 1A: 'approximately $19.7 billion (or 69% of consolidated net sales ... contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.'
SEC 10-K · filed Feb 2026
LOWOutside partyCustomer
11%

top five U.S. customers

10-K Item 1A: 'our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile is dominated by its group purchasing organization channel. Approximately $19.7 billion, or 69% of consolidated net sales, flowed through contracts with the largest GPOs — specifically Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance — a high-share exposure with a dependency character. GPO relationships are governed by formal contracts whose terms can be renegotiated, and concentration across three large purchasing organizations means that a pricing or contractual change at even one of those counterparties would affect a meaningful share of net sales. At the individual customer level within the broader book, the top five U.S. customers represented approximately $3.2 billion, or approximately 11.3% of net sales — a small-share exposure. The contrast between the high-share GPO concentration and the small-share direct-customer concentration illustrates that the primary dependency is channeled through intermediary purchasing organizations rather than concentrated end-use customers; individual hospital or health system accounts are relatively diffuse below the GPO layer. Together, the profile points to GPO channel risk as the central concentration. Because the GPO contracts aggregate hospital purchasing power, a renegotiation or exit from one of the three named programs could affect the broader contract base rather than a single hospital. Investors should monitor the terms and tenure of agreements with Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance as the primary variable in this concentration.

For the engine’s reasoning on MDLN’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Instruments & Supplies

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BAXBaxter International Inc.1203
ATRAptarGroup, Inc.1102
BDXBecton, Dickinson and Company1102
MDLNMedline Inc.1012
ALGNAlign Technology, Inc.1001
AVTRAvantor, Inc.1001

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks MDLN Concentration risk